发明名称 |
Novel composition for the treatment of cystic fibrosis |
摘要 |
The present invention provides a composition comprising at least one prostacyclin or prostacyclin analogue or a pharmaceutically acceptable salt thereof and at least one phosphodiesterase (PDE) 4inhibitor and optionally a further PDE inhibitor for use in preventing or treating cystic fibrosis by selectively increasing the cAMP levels in bronchoepithelial cells. |
申请公布号 |
AU2012215606(B2) |
申请公布日期 |
2016.12.22 |
申请号 |
AU20120215606 |
申请日期 |
2012.02.03 |
申请人 |
Scipharm Sarl |
发明人 |
Freissmuth, Michael;Gloeckel, Christina;Koenig, Xaver;Keuerleber, Simon |
分类号 |
A61K9/00;A61K9/28;A61K9/48;A61K31/192;A61K31/343;A61K31/37;A61K31/4015;A61K31/404;A61K31/4174;A61K31/427;A61K31/437;A61K31/44;A61K31/444;A61K31/472;A61K31/498 |
主分类号 |
A61K9/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|